Cardiac Disease
The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients. N Engl J Med 2000; 342:145-53.
CCS Guideline Programs:
Diabetes
CDA Guidelines
The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008; 358; 2545-59.
The ADVANCE Collaborative Group. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008; 358:2560-72.
Dyslipidemia
Canadian dyslipidemia guidelines
CCS Guideline Programs - Dyslipidemia
Hypertension
CHEP Guidelines
Effects of an Angiotensin-Converting-Enzyme Inhibitor, Rampril, On Cardiovascular Events in High-Risk Patients. HOPE investigators. NEJM. 342(3): 145-53
CCS Guidelines Apps
Atrial Fibrillation Guidelines
iPhone, iPad and iPhone Touch
Blackberry
Driving Guidelines
Lipid Guidelines
CHEP Canadian Hypertension Recommendations App via iTunes